Company Filing History:
Years Active: 2024
Title: Innovations of Cheol Hwa Hong in Antigen-Presenting Cell Technology.
Introduction
Cheol Hwa Hong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunotherapy through his innovative research and development of artificial antigen-presenting cells.
Latest Patents
Cheol Hwa Hong holds a patent titled "Artificial antigen-presenting cell prepared from HLA-null cell line by using multiplex CRISPR-CAS9 system and use thereof." This invention relates to a novel artificial antigen-presenting cell that can present antigens of HLA class I and includes a co-stimulatory molecule group. The cell is generated using a multiplex CRISPR-Cas9 system and is designed to stimulate T cells. This technology has potential applications in treating tumors, pathogenic infections, and autoimmune diseases.
Career Highlights
Cheol Hwa Hong is associated with the Catholic University of Korea Industry-Academic Cooperation Foundation. His work focuses on advancing the understanding and application of antigen-presenting cells in therapeutic settings.
Collaborations
He collaborates with notable colleagues, including Tai Gyu Kim and Hyun Jung Sohn, to further enhance the research and development of immunotherapeutic agents.
Conclusion
Cheol Hwa Hong's innovative work in the field of artificial antigen-presenting cells represents a significant advancement in immunotherapy. His contributions have the potential to impact the treatment of various diseases, showcasing the importance of research and collaboration in the scientific community.